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Formation of MacroH2A-Containing
Senescence-Associated Heterochromatin Foci
and Senescence Driven by ASF1a and HIRA
cells (Howard, 1996; Narita et al., 2003). Specifically,
Lowe and coworkers showed that in senescent cells,
proliferation-promoting genes are incorporated into
transcriptionally silent heterochromatin (senescence-
associated heterochromatin foci, SAHF) (Narita et al.,
Rugang Zhang,1 Maxim V. Poustovoitov,1,2
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Sally M. Daganzo,3,4 Jan P. Erzberger,3
Ilya G. Serebriiskii,1 Adrian A. Canutescu,1
Roland L. Dunbrack,1 John R. Pehrson,5
2003). Accordingly, it was proposed that formation ofJames M. Berger,3 Paul D. Kaufman,3,4
SAHF contributes to exit from the cell cycle in senescentand Peter D. Adams1,*
cells. In an attempt to understand the principles that1Fox Chase Cancer Center
govern such chromatin changes, we have investigatedPhiladelphia, Pennsylvania 19111
the mechanisms responsible for formation of hetero-2Russian State Medical University
chromatin in senescent cells.Moscow 117 869
Heterochromatin is condensed and modified, tran-Russia
scriptionally silent chromatin, and inclusion of genes3Lawrence Berkeley National Laboratory
into such chromatin promotes their stable repressionBerkeley, California 94720
(Richards and Elgin, 2002). Constitutive heterochroma-4Department of Molecular and Cell Biology
tin is condensed throughout the cell cycle and is foundUniversity of California, Berkeley
at repetitive DNA sequences, such as pericentromeres.Berkeley, California 94720
It is typically characterized by histone hypoacetylation,5University of Pennsylvania School
methylation of lysine9 of histone H3 (Me-K9-H3), andof Veterinary Medicine
binding of heterochromatin proteins 1 (HP1, , ) (Mai-Philadelphia, Pennsylvania 19104
son and Almouzni, 2004). Facultative heterochromatin
is inducible heterochromatin and is most prominent at
the single X chromosome of female cells that is silencedSummary
during embryogenesis (X inactivation). Facultative het-
erochromatin of the inactive X chromosome contains aIn senescent cells, specialized domains of transcrip-
histone H2A variant, macroH2A, that is actually a familytionally silent senescence-associated heterochro-
of three related proteins (macroH2A1.1, 1.2, and 2,matic foci (SAHF), containing heterochromatin pro-
where 1.1 and 1.2 are splice variants) (see Figure 4B;teins such as HP1, are thought to repress expression
Costanzi and Pehrson, 1998, 2001). Family membersof proliferation-promoting genes. We have investi-
have an N-terminal histone H2A-like domain and agated the composition andmode of assembly of SAHF
C-terminal “macro domain” of 200 residues that isand its contribution to cell cycle exit. SAHF is enriched
unrelated to other histones. MacroH2A-containing chro-in a transcription-silencing histone H2A variant, mac-
matin, assembled in vitro, is resistant to ATP-dependentroH2A. As cells approach senescence, a known chro-
remodeling proteins and binding of transcription factorsmatin regulator, HIRA, enters PML nuclear bodies,
(Angelov et al., 2003), thus supporting a direct role inwhere it transiently colocalizes with HP1 proteins,
gene silencing.prior to incorporation of HP1 proteins into SAHF. A
SAHF is facultative heterochromatin, because it is in-physical complex containing HIRA and another chro-
duced in senescent cells. Formation of SAHF dependsmatin regulator, ASF1a, is rate limiting for formation
on the pRB tumor suppressor pathway and is thoughtof SAHF and onset of senescence, and ASF1a is re-
to repress expression of proliferation-promoting E2Fquired for formation of SAHF and efficient senes-
target genes, such as cyclin A, DHFR, and Mcm3 (Narita
cence-associated cell cycle exit. These data indicate
et al., 2003). Apart from inclusion of common hetero-
that HIRA and ASF1a drive formation of macroH2A- chromatin markers such as Me-K9-H3 and HP1 proteins,
containing SAHF and senescence-associated cell cy- the molecular constituents of SAHF are poorly charac-
cle exit, via a pathway that appears to depend on flux terized.Moreover, we do not know the factors thatmedi-
of heterochromatic proteins through PML bodies. ate SAHF formation. Finally, the contribution of SAHF
to the cell cycle exit associated with senescence has
Introduction not been tested.
The yeast Hir1p, Hir2p, and Asf1p proteins, and/or
Most normal human cells undergo a limited number of their evolutionarily conserved orthologs, exhibit chro-
cell divisions, eventually entering an irreversibly arrested matin assembly activity in vitro and copurify from cell
state, through either terminal differentiation or senes- extracts with newly synthesized histones (Krawitz et al.,
cence. Both senescence and differentiation are accom- 2002; Ray-Gallet et al., 2002; Sharp et al., 2001; Tagami
panied by reorganization of chromatin structure. This et al., 2004; Tyler et al., 1999). In addition, they contribute
reorganization is well documented in differentiated cells to formation of heterochromatin and silencing of telo-
and is thought to directly contribute to the altered cell meres, pericentromeres, and mating loci in vivo (Kauf-
phenotype (Kosak and Groudine, 2004). Chromatin man et al., 1998; Le et al., 1997; Moshkin et al., 2002;
structure is also extensively remodeled in senescent Sharp et al., 2002; Singer et al., 1998). The three proteins
physically associate and this interaction is necessary
for telomeric silencing by Asf1p (Daganzo et al., 2003;*Correspondence: peter.adams@fccc.edu
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Sharp et al., 2001; Sutton et al., 2001). Interestingly, they colocalize with SAHF and were reminiscent of PML nu-
clear bodies (Figure 2A, 4 days postinfection with Ras).are also repressors of histone genes normally expressed
in S-phase (Nelson et al., 2002; Spector et al., 1997; PML bodies are 0.2–1.0 M diameter structures that
contain the PML protein and numerous other proteinsSutton et al., 2001). Taken together, these data suggest
that these three proteins contribute to formation of tran- and are implicated in induction of senescence. Specifi-
cally, PML bodies become larger and more numerousscriptionally silent heterochromatin structures through
chromatin assembly and/or compaction and also re- as cells enter senescence, ectopic expression of PML
induces senescence, and shRNA-mediated knockdownpress expression of at least one class of proliferation-
linked genes, the replication-dependent histones. of PML impairs senescence (de Stanchina et al., 2004;
Ferbeyre et al., 2000; Pearson et al., 2000). Significantly,Human cells contain two orthologs of Asf1p, ASF1a
and ASF1b, as well as a single protein, HIRA, which HP1 proteins have been previously reported to localize
to PML bodies, although no link to senescence wasis a fusion of yeast Hir1p and Hir2p. In light of data
summarized above, wewonderedwhether human HIRA, defined (Everett et al., 1999; Seeler et al., 1998). To test
whether the observed HP1 proteins are contained inASF1a, and ASF1b promote formation of SAHF and cell
cycle exit in senescent cells. Consequently, we investi- PML bodies, young and senescent WI38 cells were co-
stained with antibodies to HP1 and PML. No specificgated the structure of SAHF, its mode of assembly,
and contribution to cell cycle arrest. Here we present colocalization between HP1 and PML bodies was ob-
served in young, nonsenescent WI38 cells (Figure 2, 1evidence for a HIRA/ASF1a-dependent pathway that
drives formation of macroH2A- and HP1-containing daypostinfection andcontrol infectedcells, cellswith no
DAPI foci). However, as cells approached senescence,SAHF, thus contributing to cell cycle exit in senescent
cells. there was marked colocalization between HP1 and
PML foci (Figure 2, 4 days postinfection, cells with inter-
mediate DAPI foci). Finally, in late senescent cells, theResults
extent of colocalization between HP1 and PML de-
clined (Figure 2, 10 days after infection, cells with well-SAHF Are Enriched in the Histone
formed DAPI foci). Strikingly, incorporation of HP1 intoVariant macroH2A
SAHF occurred after its localization to PML bodies, and,To better characterize SAHF (defined by DAPI foci) at
at the same time as localization to PML bodies declined,the molecular level, we analyzed SAHF in primary WI38
incorporation into chromatin reached a maximum (Fig-fibroblasts for markers of heterochromatin. As reported
ure 2B). Each of the HP1 subtypes behaved the same,previously (Narita et al., 2003), SAHF contained Me-K9-
except HP1 showed a higher level of localization toH3 and HP1, , and  (Figures 1A–1E). Also, we ob-
PML bodies in young, growing cells (data not shown).served that SAHF are enriched in all three members of
In sum, these data show that HP1 proteins transientlythe variant histone macroH2A family (Figure 1 and data
localize to PML bodies in the early stages of senes-not shown). However, not all SAHF containedmacroH2A
cence, prior to their stable incorporation into SAHF.foci (Figure 1F, cell marked with asterisk). In fact, time
course analyses showed that macroH2A was incorpo-
rated into SAHF after their appearance by DAPI staining. HIRA also Enters PML Bodies prior
This was true regardless of whether senescence was to Formation of SAHF
induced by an activated oncogene (Figure 1G) or ex- The first clue that HIRA contributes to SAHF came from
tended growth in culture. After 50 and 55 population its localization in primary and transformed human cells.
doublings (PD) in culture, approximately 50% and 97%, In asynchronously growing transformed cell lines of var-
respectively, of cells with DAPI foci contained colocaliz- ious tissue origins, e.g., U20S, HCT116, WI38-VA13,
ing macroH2A foci (data not shown; see also Figure 3C). SAOS2, MDAMB435, MCF7, HeLa, and HL60, HIRA was
Thus, concentration of macroH2A in SAHF is not simply diffused throughout the nucleus. In contrast, in a pro-
a result of increased chromatin density at these sites. portion of primary human cells, e.g., WI38, IMR90, and
Consistent with macroH2A playing key role in stable MRC5, HIRA was concentrated in 10–30 discrete nu-
formation of SAHF, we found that its knockdown by a clear foci per cell, as well as being diffused throughout
targeted short-hairpin (sh) RNA greatly decreased accu- the nucleus (Supplemental Figure S1A at http://www.
mulation of SAHF (data not shown). However, this treat- developmentalcell.com/cgi/content/full/8/1/19/DC1/
ment also caused severe defects in cell cycle progres- and data not shown).
sion, making it difficult to assess the specificity of this One difference between primary and transformed
phenotype. Regardless, our data show that macroH2A cells is that the former, but not the latter, become senes-
is specifically enriched in SAHF, as a relatively late event cent. Therefore, we hypothesized that the HIRA foci are
in their formation. Notably, incorporation of macroH2A linked to onset of senescence. To test whether HIRA
into the inactive X chromosome is also a relatively late foci formed during senescence after extended cell cul-
event (Okamoto et al., 2004). ture, we grew WI38 fibroblasts from PD#29 to senes-
cence at PD#55 and analyzed the cells for HIRA foci
and markers of senescence, senescence-associatedHP1 Proteins Are Transiently Recruited to PML
Bodies prior to Incorporation into SAHF -galactosidase (SA -gal; Dimri et al., 1995), SAHF
(DAPI foci), and colocalizingmacroH2A foci. The numberClose inspection of HP1, , and  staining patterns, in
cells approaching senescence, revealed that not all HP1 of cells with SA -gal, SAHF, and macroH2A foci in-
creased exponentially as the cells approached senes-foci colocalized with SAHF. Frequently, we also ob-
served 10–30 bright, round nuclear foci that failed to cence (Figures 3A–3C). The number of cells with HIRA
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Figure 1. SAHF Is Enriched in macroH2A
(A–E) Senescent WI38 cells stained with DAPI and antibodies to macroH2A1.2 and (A) di-Me-K9-H3, (B) tri-Me-K9-H3, (C) HP1, (D) HP1, and
(E) HP1 as indicated. Images obtained by epifluorescence with a cooled CCD camera.
(F)WI38 cells (PD#53) stainedwith antibodies tomacroH2A1.2 andwith DAPI. Asteriskmarks a cell that contains DAPI foci withoutmacroH2A1.2.
(G) Growing WI38 cells were infected with a retrovirus encoding activated Ras or a control virus. Infected cells were selected in puromycin
and then fixed and stained with DAPI and antibodies to macroH2A1.2 and di-Me-K9-H3. Results were quantitated by scoring 100 cells on
each slide, from two independent experiments.
foci also increased, although these appeared earlier cells with a retrovirus encoding oncogenic RasV12. This
treatment induced HIRA foci in nearly 100% of the cellsthan othermarkers of senescence and increased linearly
over time (Figures 3B and 3C). Despite the correlated (Figure 3D). To further test whether HIRA foci are linked
to senescence-associated exit from the cell cycle, asyn-appearance of HIRA foci and SAHF in senescent cells,
in individual cells there was no specific colocalization chronously growing WI38 cells were labeled with 5-
BrdU for 1, 18, or 24 hr immediately prior to harvesting.between the two (Figure 3B). To test whether HIRA foci
are induced by activated oncogenes, we infected WI38 In middle-aged cells (PD#40), approximately 20% of the
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Figure 2. HP1 Is Transiently Recruited to
PML Bodies prior to Formation of SAHF
(A) WI38 cells were infected with a retrovirus
encoding an activated Ras oncogene. The in-
fected cells were selected in puromycin and
fixed and stained with DAPI and antibodies
to HP1 and PML 1, 4, or 10 days later.
(B) As (A), except the percent of cells with
DAPI foci, colocalizing HP1/PML foci, and
colocalizing HP1/DAPI foci in Ras and con-
trol infected cells were quantitated by scoring
100 cells from each slide.
total cells were in S-phase at any time, as determined bodies virtually simultaneously (data not shown), prior
to formation of SAHF (Figures 2B and 3C). Eventually,by a 1 hr pulse with 5-BrdU (Supplemental Figure S1B).
Over a 24 hr pulse period, most cells entered S-phase however, the steady-state abundance of HP1 proteins
decreases in PML bodies and, instead, they accumulateand labeled with 5-BrdU. The cells containing HIRA foci
also incorporated5-BrdU, butmuch less efficiently than in SAHF (Figure 2B).
In light of these data, and since HIRA and ASF1athe bulk population of cells. Thus, cells with HIRA foci
pass through S-phase less frequently than thosewithout orthologs contribute to heterochromatin formation in
yeast and flies (see Introduction), we hypothesized thatHIRA foci. Taken together, these results suggest that in
cells approaching senescence and exit from the cell HIRA and ASF1a promote formation of HP1- and mac-
roH2A-containingSAHF in senescent human cells. Alter-cycle, a proportion of HIRA is recruited to nuclear foci.
These HIRA foci are, like the HP1 foci, reminiscent of natively, relocalization of the proteins in senescent cells
could reflect a function unrelated to chromatin structure.PMLnuclear bodies (Borden, 2002). Therefore, weasked
whether HIRA foci are also in PML bodies. Indeed, by To test whether relocalization of HIRA was specifically
linked to changes in chromatin structure, we askedconfocal and epifluorescence microscopy, HIRA foci
colocalized perfectly with PML and another marker of whether other treatments that directly affect chromatin
structure also cause relocalization of HIRA. WI38 cellsPML bodies, SP100 (Figure 3E and Supplemental Figure
S1C). When WI38 cells were infected with a retrovirus were treated with various drugs and genotoxic stresses.
Only those known to directly perturb chromatin struc-encoding wild-type HA-tagged HIRA (or a fragment
spanning residues 421–729, HA-HIRA[421-729]), the ture, namely trichostatin A (TSA) and sodium butyrate
(NaBu), recruited HIRA to PML bodies (Supplementalstaining observed with anti-HA antibodies also colocal-
ized with PML (Supplemental Figure S1D and data not Figures S2A–S2C). TSA and NaBu are histone deacety-
lase (HDAC) inhibitors that promote histone acetylationshown). PML bodies were observed in all cells as re-
ported previously, but HIRA only colocalized with PML and relaxation of chromatin structure (Johnstone, 2002).
Genotoxic stresses (hydroxyurea [HU], ultraviolet lightin a subset of, presumably, presenescent or senescent
cells (Supplemental Figure S1E). In sum, these data [UV], and ionizing radiation [IR]) and phosphatase inhibi-
tors (sodium orthovanadate [NaV] and okadaic acidshow that HIRA, like HP1 proteins, is recruited to PML
bodies as cells enter senescence. Indeed, a comparison [OA]) had no effect over a range of doses and times
(Supplemental Figure S2A and data not shown). Forma-of the two proteins showed that HIRA andHP1 colocal-
ize in PML bodies (Figure 3F) and the two enter PML tion of HIRA foci was not due to cell cycle perturbation
Formation of Senescent Heterochromatin
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Figure 3. HIRA Is Localized to PML Bodies
and Colocalizes with HP1 as Cells Enter
Senescence
(A) Growing and senescentWI38 cells (PD#29
and #55, respectively) fixed and stained for
expression of SA -gal.
(B) As (A), but cells stained with DAPI and
antibodies to HIRA.
(C) WI38 cells were passaged from PD#29 to
senescence at PD#55. At every other PD, the
cells were stained for SA -gal, with antibod-
ies to HIRA and macroH2A1.2 and with DAPI
to visualize SAHF.
(D) WI38 cells were infected with a control or
RasV12-expressing retroviruses, selected in
puromycin for 8 days, and stained with DAPI
and antibodies to HIRA.
(E) WI38 cells stainedwith antibodies to HIRA
and PML and visualized by confocal mi-
croscopy.
(F) WI38 cells were infected with a retrovirus
encoding activated Ras, drug selected, and
then stained with antibodies to HIRA, HP1,
and PML.
by TSA and NaBu, because TSA, NaBu, HU, UV, and These results are consistent with a role for HIRA and
ASF1a in induction of SAHF and senescence.IR had comparable effects on the cell cycle (data not
shown). Consistent with the idea that recruitment of
HIRA to PML bodies and insertion of macroH2A into Induction of SAHF by HIRA and ASF1a Requires
chromatin are in the same pathway, cells treated with Their Physical Interaction
TSA and NaBu (but not HU, UV, IR, OA, or NaV) also The yeast orthologs of HIRA and ASF1a physically inter-
accumulated nuclear foci ofmacroH2A that did not colo- act, and human HIRA and ASF1a copurify from cells,
calizewith HIRA foci (Supplemental Figure S2Dand data suggesting that they are in the same complex (Sharp et
not shown). In sum, recruitment of HIRA to PML bodies al., 2001; Sutton et al., 2001; Tagami et al., 2004). Indeed,
correlates tightly with altered chromatin structure and endogenous HIRA and ASF1a coimmunoprecipitated
deposition of macroH2A into chromatin. In turn, this from asynchronously growing WI38 cells, confirming
supports the notion that the redistribution of HIRA in that they directly or indirectly associate in cells (Figures
presenescence is linked to construction of macroH2A- 5A and 5B). Significantly, human HIRA did not interact
containing SAHF. with ASF1b at endogenous levels in primary human
cells, or in vitro (Figures 5B and 5C). Similarly, Tagami
et al. (2004) previously found that HIRA copurified withHIRA and ASF1a, but Not ASF1b, Are Rate Limiting
for Formation of SAHF ASF1a but not ASF1b. The finding that ASF1a binds to
HIRA and induces SAHF, whereas ASF1b does neither,To test directly whether HIRA and ASF1a promote for-
mation of SAHF, primary human fibroblasts were in- is consistent with the idea that induction of SAHF de-
pends upon the interaction between ASF1a and HIRA.fected with retroviruses encoding HIRA, ASF1a, or both.
HIRA and ASF1a each caused cells to assume markers To test this directly, we compared a panel of ASF1a
mutants for binding toHIRA and induction ofmacroH2A-of senescence, including a large flat morphology, ex-
pression of SA -gal activity, and macroH2A-containing and HP1-containing SAHF, as well as SA -gal. This
panel included alanine substitution mutants ASF1aSAHF. The effect was more pronounced when both pro-
teins were coexpressed (Figures 4A and 4B). Strikingly, (ED36-37AA) and ASF1a(VGP62-64AAA), which we
showed previously do not bind to HIRA (Daganzo et al.,ASF1b was inactive in all assays (Figures 4A and 4B).
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Figure 4. Ectopic Expression of HIRA and
ASF1a Induces Senescence and macroH2A-
Containing SAHF
(A) WI38 cells were infected with control, HA-
ASF1a,HA-ASF1b, orMyc-HIRAencoding re-
troviruses, as indicated. The cells were se-
lected in puromycin and neomycin and
stained for SA -gal expression after 8 days.
The histogram shows results from 100 cells
of each infection. Results are means of three
independent experiments. ExtractswereWest-
ern blotted with anti-HA and anti-myc.
(B) Cells infected as in (A) were stained with
antibodies to macroH2A1.2 and DAPI. White
arrows mark inactive X chromosome.
2003), and three additional substitution mutants that binding (ASF1a(VGP62-64AAA)) (Figure 5D; Supplemen-
tal Figures S3A and S4; Daganzo et al., 2003). Basedretain HIRA binding, ASF1a(E,E121,124A,A), ASF1a(P,-
V144,146A,A), and ASF1a(V45A) (Figure 5D and Supple- on these results, we substituted residues 31–37 and
the C terminus of ASF1a in place of the correspondingmental Figures S3A and S4). There was an excellent
correlation between ASF1a’s ability to bind to HIRA, ASF1b sequences, to create ASF1b-a. This protein
bound more efficiently to HIRA in vitro and in vivo, con-both in vitro and in vivo, and its ability to induce mac-
roH2A- and HP1-containing SAHF and SA -gal (Figures firming that the swapped sequences are key determi-
nants of HIRA binding (Figure 5D and Supplemental Fig-5D and 5E and Supplemental Figures S3A, S4, S5A, and
S5B). This supports the notion that induction of SAHF ure S3A; note that when ectopically overexpressed
in vivo, ASF1b wild-type did bind to HIRA. However,by ASF1a depends on its physical interaction with HIRA.
If so, ASF1b might fail to induce SAHF because it since endogenous ASF1b does not bind to endogenous
HIRA [Figure 5B; Tagami et al., 2004], this is likely todoes not bind to HIRA. To test this, we designed a
variant of ASF1b that binds more efficiently to HIRA. reflect nonspecific bindingdue to high-level overexpres-
sion). In addition, ASF1b-a was a more potent inducerASF1a and ASF1b are 71% identical over their entire
length. However, two regions are quite poorly con- of macroH2A-containing SAHF and SA- gal, compared
to ASF1b wild-type (Figure 5E). This supports the notionserved, perhaps accounting for their different HIRA
binding properties (Figure 5F). First, the C-terminal 50 that the failure of ASF1b to induce SAHF stems, at least
in part, from its failure to bind HIRA. Taken together,residues of the two proteins show low sequence conser-
vation. Second, residues 31–37 of ASF1a (IEDLSED) are the results in Figure 5 strongly argue that the ability
of ASF1a to induce SAHF depends upon its ability toquite poorly conserved in ASF1b. Supporting the signifi-
cance of this N-terminal sequence, we already showed bind HIRA.
We then asked whether the ability of HIRA to inducethat mutation of residues 36 and 37 to alanine inacti-
vated HIRA binding (ASF1a(ED36-37AA)) (Figure 5D and SAHF depends on its binding to ASF1a. To do this, we
tested a panel of HIRA deletion mutants for their abilitySupplemental Figure S3A). Moreover, substitution of an-
other three residues that, in a model of ASF1a based to bind to ASF1a and induce SAHF. There was a strong
correlation between binding to ASF1a, both in vitro andon the crystal structure of yeast Asf1p, are folded adja-
cent to this N-terminal sequence also inactivated HIRA in vivo, and induction of macroH2A-containing SAHF
Formation of Senescent Heterochromatin
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Figure 5. Induction of macroH2A-Containing
SAHF by ASF1a Requires Its Interaction
with HIRA
(A) Extracts fromWI38 cells were immunopre-
cipitated with anti-ASF1a (A87, A88) or con-
trol (A87 preimmune serum [PI], A88 PI) and
Western blotted with anti-HIRA (WC119) or
anti-ASF1a (A88).
(B) As (A), except extracts were immunopre-
cipitated with anti-HIRA (WC15, WC19,
WC117, WC119, D34) or control (419, RM).
Anti-ASF1a/b Western blot was with A87
and A88.
(C) In vitro translated 35S-labeled Myc-ASF1a
WT and Myc-ASF1b WT were incubated with
35S-labeled HA-HIRA and immunoprecipi-
tated with anti-HA antibodies.
(D) In vitro translated 35S-labeled HA-HIRA,
Myc-ASF1a WT, Myc-ASF1b WT, mutants of
Myc-ASF1a, and Myc-ASF1b-a were incu-
bated and immunoprecipitated with antibod-
ies to HA.
(E) WI38 cells were infected with retroviruses
encoding HA-tagged versions of ASF1 pro-
teins from (D), the cells were selected in puro-
mycin for 12 days and then scored for SA
-gal, SAHF (DAPI foci), and macroH2A1.2
foci. Results are means of three independent
experiments. Cell extracts were Western
blotted with anti-HA antibodies to detect ec-
topic proteins.
(F) A schematic comparing ASF1a and ASF1b
primary sequences. The percent identity in
each region is indicated.
(Figure 6 and Supplemental Figure S3B). Of particular ASF1a Is Required for Senescence-Associated
Cell Cycle Exitnote, a 37 amino acid deletion of the evolutionarily con-
served B domain (HIRA(delB)) (Kirov et al., 1998; Nelson To test whether ASF1a is also required for cell cycle
exit, the cells fromFigures 7A and 7Bwere pulse-labeledet al., 2002) inactivated HIRA in all assays, whereas all
active mutants contained this entire domain (Figure 6C). with 5-BrdU. Up until 6 days after infection, knockdown
of ASF1a resulted in a 4- to 5-fold increase in 5-BrdU-We conclude that the ability of HIRA to induce mac-
roH2A-containing SAHF depends on its ability to bind positive cells, compared to cells expressing activated
Ras plus a control shRNA (Figure 7C). Importantly,ASF1a through the evolutionarily conserved B-domain.
Together, Figures 5 and 6 and Supplemental Figures knockdown of ASF1a did not affect the cell cycle distri-
bution of cells growing in the absence of an activatedS3, S4, S5A, and S5B show that induction of macroH2A/
HP1-containing SAHF by HIRA and ASF1a depends on Ras oncogene (Figure 7C). We conclude that ASF1a
does not detectably inhibit the cell cycle in normal grow-a physical interaction of the two proteins.
ing cells, but does contribute to efficient senescence-
associated cell cycle exit and formation of SAHF.ASF1a Is Required for Formation of SAHF
To test whether the HIRA/ASF1a complex is required Together, these results are consistent with a model
whereby ASF1a is required for cell cycle exit due to itsto reshape chromatin in senescent cells, we infected
primary human fibroblasts with a retrovirus encoding a contribution to SAHF. In line with this idea, wild-type
HIRA, ASF1a, and all mutants that promoted SAHF alsoRasV12 oncogene, together with a retrovirus encoding
an shRNA that knocks down ASF1a, or two different forced cell cycle exit, as judged by 5-BrdU incorpora-
tion and cell proliferation assays (Figures 7D, 7E, 5E,control shRNAs to luciferase (both knocked down lucif-
erase activity [data not shown]). The shRNA to ASF1a, and 6B). Of special note, wild-type ASF1b that did not
induce SAHF did not efficiently block cell prolifera-but not control shRNAs, dramatically decreased the
number of cells with macroH2A- and HP1-containing tion, whereas the ASF1b variant that induced SAHF
(ASF1b-a) blocked proliferation very efficiently (FigureSAHF (Figures 7A and 7B and Supplemental Figures
S5C and S5D). Thus, ASF1a is required for efficient for- 7E). This is consistent with SAHF contributing to cell
cycle exit.mation of SAHF.
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have demonstrated a role for two known regulators of
chromatin structure, HIRA and ASF1a, in formation of
SAHF. Finally, we have shown that ASF1a is required
for efficient senescence-associated cell cycle exit and
have presented evidence that this is, at least in part,
through its formation of SAHF.
HIRA and ASF1a Are Rate Limiting and Necessary
for Formation of SAHF
Three lines of evidence show that HIRA and ASF1a play
a key role in formation of SAHF in senescent cells. First,
HIRA and HP1 proteins transiently colocalize in PML
bodies, prior to deposition of HP1 proteins in SAHF
(Figures 2 and 3). Second, ectopic expression of HIRA
and ASF1a in primary cells induces SAHF (Figure 4), and
the interaction between HIRA and ASF1a is necessary
to form SAHF (Figures 5 and 6). Third, ASF1a is required
for formation of SAHF (Figure 7).
Several lines of evidence indicate that HIRA and
ASF1a directly affect chromatin structure, instead of as
a secondary consequence of effects on cell proliferation
and senescence. First, recruitment of HIRA to PML bod-
ies also occurs in response to other perturbations of
chromatin structure that do not acutely induce other
markers of senescence (Supplemental Figure S2). Spe-
cifically, HIRA relocalization occurred in response to
HDAC inhibitors, TSA and NaBu. TSA and NaBu should
Figure 6. Induction of macroH2A-Containing SAHF by HIRA Re- increase demand for replication-independent chromatin
quires Its Interaction with ASF1a assembly and/or compaction in the cell (Johnstone,
(A)Wild-type in vitro translated 35S-labeledHA-HIRAWTanddeletion 2002; Lomvardas and Thanos, 2002). Thus, activation
mutants were incubated with 35S-labeled Myc-ASF1a and immuno- of the HIRA/ASF1a pathway is tightly linked to direct
precipitated with antibodies to HA.
changes in chromatin structure. Second, four mutants(B) WI38 cells were infected with retroviruses encoding HA-HIRA
that failed to induce SAHF did arrest cell proliferationWT or deletion mutants and selected for 10 days in puromycin, and
(Figures 7D, 7E, 5E, and 6B). Third, shRNA-mediated100 cells were scored for SAHF (DAPI foci), macroH2A1.2 foci, and
SA -gal. Results are means of three independent experiments. Cell knockdown of ASF1a impaired, but did not abolish, se-
extracts were Western blotted with anti-HA antibodies to detect nescence-associated cell cycle exit. Eventually, cell cy-
expression of HA-HIRA proteins (themiddle three lanes are underex- cle arrest occurred, but did so without normal assembly
posed relative to the others).
of SAHF (Figures 7B and 7C and Supplemental Figure(C) A schematic of the HIRA mutants, their binding to ASF1a, and
S6). Thus, the ability of ASF1a knockdown to abrogateinduction of SAHF. The B-domain is shaded black.
SAHF does not depend on forced re-entry into the cell
cycle. Fourth, HIRA, ASF1a, and orthologs are well-doc-
These results, together with those obtained from umented regulators of chromatin structure (see Intro-
ASF1a knockdown, show that forced assembly or dis- duction). Most notably, telomeric silencing by Asf1p in
ruption of SAHF is tightly linked to induction or abro- yeast requires binding to Hir1p (Daganzo et al., 2003).
gation of cell cycle arrest, respectively. However, forma- Likewise, induction of SAHF by HIRA and ASF1a re-
tion of SAHF is not a consequence of cell cycle exit, quires their physical interaction (Figures 5 and 6 and
because several mutants—HIRAdelB, HIRA(520-1017), Supplemental Figure S3). In sum, we have shown that
ASF1a(ED36-37AA), andASF1a(VGP62-64AAA)—arrested human HIRA and ASF1a are mechanistically related to
the cell cycle but did not induce SAHF (Figures 7D, 7E, their yeast orthologs in terms of their ability to generate
5E, and 6B). In addition, abolition of SAHF by shASF1a heterochromatin, and we have specifically linked this
was not due to cell cycle re-entry, because eventually activity to creation of SAHF in senescent human cells.
cells lacking ASF1a exited the cell cycle, but, even at
this time, they were still deficient in SAHF (Supplemental
Figure S6). These results show that ASF1a is required How Do HIRA and ASF1a Promote Deposition
of macroH2A?for efficient senescence-associated cell cycle exit and
suggest that this is, at least in part, due to its requirement De novo deposition of macroH2A into chromatin is
tightly linked to apparent activation of the HIRA/ASF1afor SAHF formation.
chromatin-remodeling pathway, as reflected by recruit-
ment of HIRA to PML bodies. Specifically, recruitmentDiscussion
of HIRA to PML bodies during senescence or after treat-
ment of cells with HDAC inhibitors, TSA and NaBu, cor-We have identified the histone H2A variant, macroH2A,
as a molecular component of SAHF. In addition, we relates with incorporation of macroH2A into chromatin
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Figure 7. ASF1a Is Required for Formation of
SAHF, which Drives Cell Cycle Exit
(A) WI38 cells were infected with retroviruses
encoding activated Ras (and resistance to
neomycin) together with shRNAs to ASF1a
or luciferase. Viruses encoding shRNAs also
encoded GFP. Cells were drug selected for
6 days and then stained with antibodies to
macroH2A1.2 and DAPI. Only GFP cells
are shown.
(B) 100 GFP cells from (A) were scored for
SAHF (DAPI foci) and macroH2A foci. Results
aremeans of three independent experiments.
Cell extracts were Western blotted to detect
RasV12 and ASF1a (with A88). Cells were
lysed by boiling in Laemmli buffer, which bet-
ter preserves the phosphorylated forms of
ASF1a, compared to the nondenaturing lysis
buffer used for IPs in Figures 5A and 5B.
(C) The cells from (A) were pulse labeled with
5-BrdU for 1 hr, and 100 GFP cells were
scored for incorporation of 5-BrdU. Results
aremeans of three independent experiments.
(D) Cells were infected with retroviruses ex-
pressing HA-tagged HIRA-derived proteins.
Relative cell proliferation rates and incorpo-
ration of 5-BrdU were determined as de-
scribed in Experimental Procedures. Results
aremeans of three independent experiments.
See Figure 6B for expression analysis.
(E) As (D) but with the indicated HA-tagged
ASF1a, ASF1b, and mutants. See Figure 5E
for expression analysis.
(Figures 1 and 3 and Supplemental Figure S2). In addi- HIRA, ASF1a, and SAHF Drive Cell Cycle Exit
All ASF1a and HIRA mutants that form SAHF also drivetion, HIRA and ASF1a are both rate limiting and ASF1a
is necessary for deposition of macroH2A (Figures 5 and cell cycle exit (Figures 7D, 7E, 5E, and 6B). Importantly,
not all HIRA and ASF1a mutants that forced exit from6 and Supplemental Figure S6). Since HIRA directs repli-
cation-independent chromatin assembly in vitro and de- the cell cycle induced SAHF, showing that cell cycle
arrest is not the cause of SAHF. Conversely, ASF1a isposits the histone H3.3 variant into chromatin, it is
tempting to speculate that HIRA and ASF1a directly required for formation of SAHF and efficient cell cycle
exit during senescence (Figures 7A–7C). Eventually,deposit macroH2A into chromatin (Ray-Gallet et al.,
2002; Tagami et al., 2004). However, two lines of evi- cells lacking ASF1a do exit the cell cycle, but they are
still deficient in SAHF (Supplemental Figure S6), showingdence argue against this model. First, we have not de-
tected a direct physical interaction between HIRA or that abrogation of SAHF is not a consequence of forced
re-entry into the cell cycle. Together, these observationsASF1a and macroH2A in vivo, as was shown for HIRA
and histone H3.3 (Ray-Gallet et al., 2002; Tagami et al., show that ASF1a promotes and is required for efficient
senescence-associated cell cycle exit and support the2004). Second, based on our mutation analyses, Asf1p/
ASF1a-mediated telomeric silencing and formation of notion that HIRA/ASF1a-mediated formation of SAHF
directly contributes to cell cycle exit during senescence.SAHF are mechanistically related (Daganzo et al., 2003).
However, yeast does not contain macroH2A. In sum, Significantly, mouse embryos lacking HIRA die between
days 7.5 and 11 of embryonic development, dependingour data show that HIRA/ASF1a activity promotes depo-
sition of macroH2A, but the HIRA/ASF1a complex does on the genetic background (Roberts et al., 2002). In
someembryos, theprimitive streakwas reported to havenot seem likely to directly deposit macroH2A. In line
with this, Jessica Tyler and coworkers recently showed many more cells than usual, and the worst affected
embryos consisted of small, relatively undifferentiatedthat yeast Asf1p has nucleosome disassembly activity
(Adkins et al., 2004), suggesting that humanASF1acould balls of cells. This phenotype is consistent with a re-
quirement for HIRA in cell cycle exit associated with thecontribute to incorporation of macroH2A by disassem-
bling chromatin, prior to insertion of macroH2A by morphogenetic movements of gastrulation. Thus, HIRA
andASF1amight also contribute to some of the changesother factors.
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Immunological and IF Techniquesin chromatin structure associated with morphogenesis
Anti-HP1were gifts of Dr. William Earnshaw and Dr. David Schultz.and cell differentiation (Kosak and Groudine, 2004). Fu-
Anti-HA (12CA5) (Roche), anti-myc (9E10) (Santa-Cruz), anti-PMLture studies will test this idea.
antibodies (AB1370 and N19) (Chemicon and Santa-Cruz, respec-
tively), anti-5-BrdU-FITC (Becton-Dickinson), anti-HP1 (Chemi-
con), anti-HP1 (Chemicon), anti-di-Me-K9-H3 (Abcam), and anti-tri-
The Role of PML Bodies Me-K9-H3 (Abcam) were from the indicated suppliers. Anti-HIRA
Our data linking PML bodies to formation of SAHF are antibodies (mouse monoclonals WC15, 19, 117, and 119 and rabbit
consistentwith previous studies implicatingPMLbodies polyclonal D34) have been described previously (Hall et al., 2001).
Anti-ASF1a antibodies (A87 and A88) were raised in rabbits againstin induction of senescence (de Stanchina et al., 2004;
GST-ASF1a.Ferbeyre et al., 2000; Pearson et al., 2000). However,
IP, IF, and Western blots were performed as described previouslythere was no significant colocalization between HIRA-
(Adams et al., 1996; Hall et al., 2001). 2- and 3-color IFwas performed
containing PML bodies and SAHF (Figures 3B and 3D). as described previously (Hall et al., 2001; Nelson et al., 2002; Ye
Still, even in senescent cells, a proportion of HIRA is et al., 2003). Image collection was by epifluorescence microscopy
diffused throughout the entire nucleus. In addition, local- recorded digitally using a cooled CCD camera or, where stated,
optical sections obtained with a confocal microscope (Figure 3E).izationofHP1proteins toPMLbodiesoccurs transiently,
SAHF (DAPI foci) were detected by staining with 0.13 g/ml DAPIprior to their deposition in SAHF (Figure 2). One model,
for 2 min at room temperature (as opposed to standard conditionsconsistent with these observations, is that the detect-
of 1 g/ml for 5 min). Detailed IF methods are available on request.
able enrichment of HIRA and HP1 proteins in PML bod- All scale bars are 10 M. Results of cell counting experiments are
ies, based on steady-state measurements, reflects a expressed as means with error bars showing SD.
dynamic process in which HP1 proteins exit PML bodies
and translocate to SAHF. Whether HIRA shuttles be- Retroviruses and shRNAs
The following plasmids were used for generating retroviruses:tween PML bodies and nascent SAHF or whether HIRA
pBABE-puro or neo H-Ras V12 (gift of Dr. Robert A. Weinberg);somehowpromotesSAHFwhile localized toPMLbodies
pQCXIP(Clontech)-HA-ASF1a, HA-ASF1b, HA-HIRA, and deriva-is not yet clear. Either way, according to this model,
tives; pQCXIN(Clontech)-Myc-HIRA; and pQCXIP-GFP with the U6
PML bodies and HIRA play a catalytic role in formation promoter shASF1a/sh-luciferase cassette subcloned into the 3LTR.
of SAHF. Thismodel is consistent with real-time imaging The shRNA to ASF1a (sense strand GCGTAACTGTTGTGCTAAT
TACTTGTACC) was designed using the approach described by Dr.studies of other nuclear bodies, such as nuclear speck-
Greg Hannon.les (Phair and Misteli, 2000) and Cajal bodies (Dundr et
Retroviral-mediated gene transfer was performed using the Phoe-al., 2004) and with the known role of PML bodies in
nix packaging cells (Dr. Gary Nolan, Stanford University). Briefly,assembly/modification of macromolecular regulatory
Phoenix cells were transfected by the calcium-phosphate method
complexes, such as those containing p53 and Mad pro- with retroviral plasmid DNA and a plasmid encoding vesicular sto-
teins (Fogal et al., 2000; Guo et al., 2000; Khan et al., matitis virus glycoprotein (VSV-G). Virus-containing medium was
collected, supplemented with 8 g/ml of polybrene (Sigma), and2001; Pearson et al., 2000).
incubated with target WI38 cells at 37C for 24 hr. Frequently, aIntact PMLbodies possess tumor suppressor activity.
second round of infection was performed on the same target cells.Specifically, disruption of PML bodies promotes cell
Infected cells were purified by drug selection (3 g/ml puromycintransformation and their reconstitution correlates with
or 500 g/ml G418).
transformation suppression (Dyck et al., 1994; Kastner
et al., 1992; Koken et al., 1994; Wang et al., 1998; Weis Other Techniques
et al., 1994). Disruption of PML bodies and inactivation In vitro transcription and translation of proteins andWestern blotting
was described previously (Adams et al., 1996; Nelson et al., 2002).of the linked HIRA/ASF1a-mediated SAHF assembly
SA -gal in senescent cells was assayed as described previouslypathway might result in failure to exit the cell cycle and
(Dimri et al., 1995).cell transformation. If so, in some cases, genetic alter-
ations of HIRA and ASF1a might also contribute to cell
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